Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia (Q42812819)

7 November 2017

Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia (English)

1 reference

7 November 2017

4

1 reference

7 November 2017

Naski MC

1

1 reference

7 November 2017

Wang Q

series ordinal

2

1 reference

7 November 2017

Xu J

series ordinal

3

1 reference

7 November 2017

language of work or name

English

0 references

publication date

1 June 1996

1 reference

7 November 2017

1 reference

7 November 2017

13

1 reference

7 November 2017

233-237

1 reference

7 November 2017

2

1 reference

https://scigraph.springernature.com/pub.10.1038/ng0696-233

7 November 2017

0 references

cites work

Variation of quantitative and qualitative changes of enchondral ossification in heterozygous achondroplasia

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

Activation and inhibition of erythropoietin receptor function: role of receptor dimerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Thanatophoric dwarfism.

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3.

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185.

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Constitutive activation of fibroblast growth factor receptor-2 by a point mutation associated with Crouzon syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

The fourth immunoglobulin domain of the stem cell factor receptor couples ligand binding to signal transduction

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Fibroblast-growth-factor receptor mutations in human skeletal disorders

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Functions of fibroblast growth factors and their receptors

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Crystal structure of the tyrosine kinase domain of the human insulin receptor

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Identification of soluble forms of the fibroblast growth factor receptor in blood

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Xenopus embryos regulate the nuclear localization of XMyoD

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Fibroblast growth factor receptor levels decrease during chick embryogenesis

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Constitutive activation of fibroblast growth factor receptor 3 by the transmembrane domain point mutation found in achondroplasia

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3.

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Fibroblast growth factor receptor 3 is a negative regulator of bone growth

1 reference

https://api.crossref.org/works/10.1038%2FNG0696-233

7 January 2021

Identifiers

DOI

10.1038/NG0696-233

1 reference

Dimensions Publication ID

7 November 2017

0 references

1 reference